dihexa cancer risk hgf c met c-met Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Tumor Microenvironment dihexa hgf c-met agonist Anti- cancer – dihexa c-met cancer risk Developing
dihexa c met cancer risk Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Activated HGF c Met Axis in Head HGF c Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR NGF axis Cell Death & Disease Recent Progress and Advances in HGF MET Targeted Therapeutic Agents for Cancer Treatment Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect
Pay in 4 interest-free payments of $5.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



